+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronavirus Test Kits Market in Europe 2024-2028

  • PDF Icon

    Report

  • 162 Pages
  • September 2024
  • Region: Europe
  • TechNavio
  • ID: 5017660
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The coronavirus test kits market in Europe is forecasted to grow by USD -8 billion during 2023-2028, accelerating at a CAGR of -9.83% during the forecast period. The report on the coronavirus test kits market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of rapid coronavirus test kits, rising focus on preventing the spread of coronavirus, and increasing government funding.

The coronavirus test kits market in Europe is segmented as below:

By End-user

  • Government
  • Non government

By Type

  • Rapid test kit
  • RT-PCR
  • Others

By Geographical Landscape

  • Europe
This study identifies the advent of SARS-CoV-2 mutation as one of the prime reasons driving the coronavirus test kits market in Europe growth during the next few years. Also, increasing demand for point-of-care diagnostics and rising adoption of rapid diagnostic products will lead to sizable demand in the market.

The report on the coronavirus test kits market in Europe covers the following areas:

  • Coronavirus test kits market in Europe sizing
  • Coronavirus test kits market in Europe forecast
  • Coronavirus test kits market in Europe industry analysis
The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market in Europe vendors that include 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Genomics Co. Ltd., Bio RAD Laboratories Inc., BioMerieux SA, BIOSYNEX SA, Bruker Corp., Co Diagnostics Inc, Danaher Corp., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., MultiplexDX, Perkin Elmer Inc., QIAGEN NV, Robert Bosch GmbH, Sd Biosensor Inc., Seegene Inc., Thermo Fisher Scientific Inc., and ZEKMED. Also, the coronavirus test kits market in Europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Country Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
2.2 Market characteristics
  • Market characteristics analysis
2.3 Value chain analysis
  • Value Chain Analysis
3 Market Sizing
3.1 Market definition
  • Offerings of companies included in the market definition
3.2 Market segment analysis
  • Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Regional - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe: Year-over-year growth 2023-2028 (%)
  • Data Table on Regional - Market size and forecast 2023-2028 ($ million)
4 Additional Value/Volume Data
4.1 Coronavirus test kits market in Europe 2020 - 2022 ($ million)
  • Market Size (value) - Data Table on Coronavirus test kits market in Europe 2020 - 2022 ($ million)
4.2 Coronavirus test kits market in Europe by End-user 2020 - 2022 ($ million)
  • Market Size (value) - Data Table on Coronavirus test kits market in Europe by End-user 2020 - 2022 ($ million)
4.3 Coronavirus test kits market in Europe by Type 2020 - 2022 ($ million)
  • Market Size (value) - Data Table on Coronavirus test kits market in Europe by Type 2020 - 2022 ($ million)
4.4 Coronavirus test kits market in Europe by country 2020 - 2022 ($ million)
  • Market Size (value) - Data Table on Coronavirus test kits market in Europe by Country 2020 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
6.3 Government - Market size and forecast 2023-2028
  • Chart on Government - Market size and forecast 2023-2028 ($ million)
  • Data Table on Government - Market size and forecast 2023-2028 ($ million)
  • Chart on Government - Year-over-year growth 2023-2028 (%)
  • Data Table on Government - Year-over-year growth 2023-2028 (%)
6.4 Non government - Market size and forecast 2023-2028
  • Chart on Non government - Market size and forecast 2023-2028 ($ million)
  • Data Table on Non government - Market size and forecast 2023-2028 ($ million)
  • Chart on Non government - Year-over-year growth 2023-2028 (%)
  • Data Table on Non government - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type
7.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
7.3 Rapid test kit - Market size and forecast 2023-2028
  • Chart on Rapid test kit - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rapid test kit - Market size and forecast 2023-2028 ($ million)
  • Chart on Rapid test kit - Year-over-year growth 2023-2028 (%)
  • Data Table on Rapid test kit - Year-over-year growth 2023-2028 (%)
7.4 RT-PCR - Market size and forecast 2023-2028
  • Chart on RT-PCR - Market size and forecast 2023-2028 ($ million)
  • Data Table on RT-PCR - Market size and forecast 2023-2028 ($ million)
  • Chart on RT-PCR - Year-over-year growth 2023-2028 (%)
  • Data Table on RT-PCR - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape - 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape - 2023-2028 (%)
9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
9.3 Russia - Market size and forecast 2023-2028
  • Chart on Russia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Russia - Market size and forecast 2023-2028 ($ million)
  • Chart on Russia - Year-over-year growth 2023-2028 (%)
  • Data Table on Russia - Year-over-year growth 2023-2028 (%)
9.4 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
9.5 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.6 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
9.7 Rest of Europe - Market size and forecast 2023-2028
  • Chart on Rest of Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of Europe - Year-over-year growth 2023-2028 (%)
9.8 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Table on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
  • Overview on factors of disruption
11.4 Industry risks
  • Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
  • Companies covered
12.2 Market positioning of companies
  • Matrix on companies position and classification
  • 3D Biomedicine Science and Technology Co. Ltd.
  • 3D Biomedicine Science and Technology Co. Ltd. - Overview
  • 3D Biomedicine Science and Technology Co. Ltd. - Product / Service
  • 3D Biomedicine Science and Technology Co. Ltd. - Key offerings
12.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
12.5 altona Diagnostics GmbH
  • altona Diagnostics GmbH - Overview
  • altona Diagnostics GmbH - Product / Service
  • altona Diagnostics GmbH - Key offerings
12.6 BGI Genomics Co. Ltd.
  • BGI Genomics Co. Ltd. - Overview
  • BGI Genomics Co. Ltd. - Product / Service
  • BGI Genomics Co. Ltd. - Key offerings
12.7 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
12.8 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key news
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
12.9 BIOSYNEX SA
  • BIOSYNEX SA - Overview
  • BIOSYNEX SA - Product / Service
  • BIOSYNEX SA - Key offerings
12.10 Bruker Corp.
  • Bruker Corp. - Overview
  • Bruker Corp. - Business segments
  • Bruker Corp. - Key news
  • Bruker Corp. - Key offerings
  • Bruker Corp. - Segment focus
12.11 Co Diagnostics Inc
  • Co Diagnostics Inc - Overview
  • Co Diagnostics Inc - Product / Service
  • Co Diagnostics Inc - Key offerings
12.12 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
12.13 Edinburgh Genetics Ltd.
  • Edinburgh Genetics Ltd. - Overview
  • Edinburgh Genetics Ltd. - Product / Service
  • Edinburgh Genetics Ltd. - Key offerings
12.14 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
12.15 QIAGEN NV
  • QIAGEN NV - Overview
  • QIAGEN NV - Product / Service
  • QIAGEN NV - Key news
  • QIAGEN NV - Key offerings
12.16 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
12.17 ZEKMED
  • ZEKMED - Overview
  • ZEKMED - Product / Service
  • ZEKMED - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
13.4 Research methodology
  • Research methodology
13.5 Data procurement
  • Information sources
13.6 Data validation
  • Data validation
13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
13.8 Data synthesis
  • Data synthesis
13.9 360 degree market analysis
  • 360 degree market analysis
13.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Europe: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Regional - Market size and forecast 2023-2028 ($ million)
Exhibits 20: Market Size (value) - Data Table on Coronavirus test kits market in Europe 2020 - 2022 ($ million)
Exhibits 21: Market Size (value) - Data Table on Coronavirus test kits market in Europe by End-user 2020 - 2022 ($ million)
Exhibits 22: Market Size (value) - Data Table on Coronavirus test kits market in Europe by Type 2020 - 2022 ($ million)
Exhibits 23: Market Size (value) - Data Table on Coronavirus test kits market in Europe by Country 2020 - 2022 ($ million)
Exhibits 24: Five forces analysis - Comparison between 2023 and 2028
Exhibits 25: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 30: Chart on Market condition - Five forces 2023 and 2028
Exhibits 31: Chart on End-user - Market share 2023-2028 (%)
Exhibits 32: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 33: Chart on Comparison by End-user
Exhibits 34: Data Table on Comparison by End-user
Exhibits 35: Chart on Government - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Data Table on Government - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Chart on Government - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Government - Year-over-year growth 2023-2028 (%)
Exhibits 39: Chart on Non government - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Data Table on Non government - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Chart on Non government - Year-over-year growth 2023-2028 (%)
Exhibits 42: Data Table on Non government - Year-over-year growth 2023-2028 (%)
Exhibits 43: Market opportunity by End-user ($ million)
Exhibits 44: Data Table on Market opportunity by End-user ($ million)
Exhibits 45: Chart on Type - Market share 2023-2028 (%)
Exhibits 46: Data Table on Type - Market share 2023-2028 (%)
Exhibits 47: Chart on Comparison by Type
Exhibits 48: Data Table on Comparison by Type
Exhibits 49: Chart on Rapid test kit - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on Rapid test kit - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on Rapid test kit - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on Rapid test kit - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on RT-PCR - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on RT-PCR - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on RT-PCR - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on RT-PCR - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 61: Market opportunity by Type ($ million)
Exhibits 62: Data Table on Market opportunity by Type ($ million)
Exhibits 63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 64: Chart on Market share By Geographical Landscape - 2023-2028 (%)
Exhibits 65: Data Table on Market share By Geographical Landscape - 2023-2028 (%)
Exhibits 66: Chart on Geographic comparison
Exhibits 67: Data Table on Geographic comparison
Exhibits 68: Chart on Russia - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Data Table on Russia - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Chart on Russia - Year-over-year growth 2023-2028 (%)
Exhibits 71: Data Table on Russia - Year-over-year growth 2023-2028 (%)
Exhibits 72: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 75: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 76: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 79: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 80: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 83: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 84: Chart on Rest of Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Data Table on Rest of Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Chart on Rest of Europe - Year-over-year growth 2023-2028 (%)
Exhibits 87: Data Table on Rest of Europe - Year-over-year growth 2023-2028 (%)
Exhibits 88: Market opportunity By Geographical Landscape ($ million)
Exhibits 89: Data Table on Market opportunity By Geographical Landscape ($ million)
Exhibits 90: Impact of drivers and challenges in 2023 and 2028
Exhibits 91: Overview on criticality of inputs and factors of differentiation
Exhibits 92: Overview on factors of disruption
Exhibits 93: Impact of key risks on business
Exhibits 94: Companies covered
Exhibits 95: Matrix on companies position and classification
Exhibits 96: 3D Biomedicine Science and Technology Co. Ltd. - Overview
Exhibits 97: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service
Exhibits 98: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings
Exhibits 99: Abbott Laboratories - Overview
Exhibits 100: Abbott Laboratories - Business segments
Exhibits 101: Abbott Laboratories - Key news
Exhibits 102: Abbott Laboratories - Key offerings
Exhibits 103: Abbott Laboratories - Segment focus
Exhibits 104: altona Diagnostics GmbH - Overview
Exhibits 105: altona Diagnostics GmbH - Product / Service
Exhibits 106: altona Diagnostics GmbH - Key offerings
Exhibits 107: BGI Genomics Co. Ltd. - Overview
Exhibits 108: BGI Genomics Co. Ltd. - Product / Service
Exhibits 109: BGI Genomics Co. Ltd. - Key offerings
Exhibits 110: Bio Rad Laboratories Inc. - Overview
Exhibits 111: Bio Rad Laboratories Inc. - Business segments
Exhibits 112: Bio Rad Laboratories Inc. - Key news
Exhibits 113: Bio Rad Laboratories Inc. - Key offerings
Exhibits 114: Bio Rad Laboratories Inc. - Segment focus
Exhibits 115: BioMerieux SA - Overview
Exhibits 116: BioMerieux SA - Business segments
Exhibits 117: BioMerieux SA - Key news
Exhibits 118: BioMerieux SA - Key offerings
Exhibits 119: BioMerieux SA - Segment focus
Exhibits 120: BIOSYNEX SA - Overview
Exhibits 121: BIOSYNEX SA - Product / Service
Exhibits 122: BIOSYNEX SA - Key offerings
Exhibits 123: Bruker Corp. - Overview
Exhibits 124: Bruker Corp. - Business segments
Exhibits 125: Bruker Corp. - Key news
Exhibits 126: Bruker Corp. - Key offerings
Exhibits 127: Bruker Corp. - Segment focus
Exhibits 128: Co Diagnostics Inc - Overview
Exhibits 129: Co Diagnostics Inc - Product / Service
Exhibits 130: Co Diagnostics Inc - Key offerings
Exhibits 131: Danaher Corp. - Overview
Exhibits 132: Danaher Corp. - Business segments
Exhibits 133: Danaher Corp. - Key news
Exhibits 134: Danaher Corp. - Key offerings
Exhibits 135: Danaher Corp. - Segment focus
Exhibits 136: Edinburgh Genetics Ltd. - Overview
Exhibits 137: Edinburgh Genetics Ltd. - Product / Service
Exhibits 138: Edinburgh Genetics Ltd. - Key offerings
Exhibits 139: F. Hoffmann La Roche Ltd. - Overview
Exhibits 140: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 141: F. Hoffmann La Roche Ltd. - Key news
Exhibits 142: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 143: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 144: QIAGEN NV - Overview
Exhibits 145: QIAGEN NV - Product / Service
Exhibits 146: QIAGEN NV - Key news
Exhibits 147: QIAGEN NV - Key offerings
Exhibits 148: Thermo Fisher Scientific Inc. - Overview
Exhibits 149: Thermo Fisher Scientific Inc. - Business segments
Exhibits 150: Thermo Fisher Scientific Inc. - Key news
Exhibits 151: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 152: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 153: ZEKMED - Overview
Exhibits 154: ZEKMED - Product / Service
Exhibits 155: ZEKMED - Key offerings
Exhibits 156: Inclusions checklist
Exhibits 157: Exclusions checklist
Exhibits 158: Currency conversion rates for US$
Exhibits 159: Research methodology
Exhibits 160: Information sources
Exhibits 161: Data validation
Exhibits 162: Validation techniques employed for market sizing
Exhibits 163: Data synthesis
Exhibits 164: 360 degree market analysis
Exhibits 165: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the coronavirus test kits market in Europe: 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Genomics Co. Ltd., Bio RAD Laboratories Inc., BioMerieux SA, BIOSYNEX SA, Bruker Corp., Co Diagnostics Inc, Danaher Corp., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., MultiplexDX, Perkin Elmer Inc., QIAGEN NV, Robert Bosch GmbH, Sd Biosensor Inc., Seegene Inc., Thermo Fisher Scientific Inc., and ZEKMED.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advent of SARS-CoV-2 mutation."

According to the report, one of the major drivers for this market is the rising adoption of rapid coronavirus test kits.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3D Biomedicine Science and Technology Co. Ltd.
  • Abbott Laboratories
  • altona Diagnostics GmbH
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • BioMerieux SA
  • BIOSYNEX SA
  • Bruker Corp.
  • Co Diagnostics Inc
  • Danaher Corp.
  • Edinburgh Genetics Ltd.
  • F. Hoffmann La Roche Ltd.
  • MultiplexDX
  • Perkin Elmer Inc.
  • QIAGEN N.V.
  • Robert Bosch GmbH
  • Sd Biosensor Inc.
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.
  • ZEKMED